The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of fluorouracil (FU), leucovorin (LV), and nanoliposomal irinotecan (nal-IRI) in previously treated advanced biliary tract cancer (NAPOLI-2).
 
Benjamin Adam Weinberg
Honoraria - Onclive; Onclive; Onclive; Onclive; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Tempus; Tempus; Tempus; Tempus
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Lilly; Lilly; Lilly; Lilly; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Isofol Medical (Inst); Isofol Medical (Inst); Isofol Medical (Inst); Isofol Medical (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences
 
Hongkun Wang
No Relationships to Disclose
 
Katrina Pedersen
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer
Speakers' Bureau - Clinical Care Options; Clinical Care Options; Clinical Care Options; Clinical Care Options
Research Funding - Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; BeiGene; BeiGene; BeiGene; BeiGene
 
Amikar Sehdev
Honoraria - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Eisai; Eisai; Eisai; Eisai; Incyte; Incyte; Incyte; Incyte
Consulting or Advisory Role - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Eisai; Eisai; Eisai; Eisai; Incyte; Incyte; Incyte; Incyte
Travel, Accommodations, Expenses - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Eisai; Eisai; Eisai; Eisai; Incyte; Incyte; Incyte; Incyte
 
Max W. Sung
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis
 
Jimmy J. Hwang
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Caris Centers of Excellence; Caris Centers of Excellence; Caris Centers of Excellence; Caris Centers of Excellence; Eisai; Eisai; Eisai; Eisai; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Ipsen; Ipsen; Ipsen; Ipsen; Lilly; Lilly; Lilly; Lilly; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Ipsen; Ipsen; Ipsen; Ipsen
Research Funding - Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Caris Centers of Excellence (Inst); Caris Centers of Excellence (Inst); Caris Centers of Excellence (Inst); Caris Centers of Excellence (Inst)